Springer Medicine

A pulmonary arterial sarcoma was mistaken as pulmonary vasculitis due to similarities between the diagnoses. But the case highlights some cardinal features of the malignancy that are not seen in vasculitis.

Children with hypertension are at an increased long-term risk for major adverse cardiac events compared with children without hypertension.

Learn how digital technology via the use of web-based and smart device apps, remote monitoring devices, and patient portals, can improve the care of adult and pediatric patients with hematologic cancers.

Hypertension is common in ICH, but inconsistent trial results have led to weak recommendations about acute blood pressure therapy. What target, timing, intensity, and agents should be used?

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

An expert-led symposium exploring the prevention and management of type 2 diabetes through dietary interventions. Highlights include discussion of the recent EASD guidelines, therapeutic diets, food types and processing, plus psychological factors that influence patient success, and the drivers of healthy eating and diabetes control.

An expert-led symposium exploring the most pertinent issues in cardio-oncology, with a focus on the new ESC guidelines. Highlights include preventative approaches in cardio-oncology, toxicity risk-stratification strategies, the clinical management of myocarditis as an adverse effect of immune checkpoint inhibitor-treatments, and the utility of biomarkers in long-term follow-up of cardiovascular disease risk in cancer patients.